Protalix BioTherapeutics, Inc. (PLX) Income Annual - Discounting Cash Flows
  • Enter your search keyword...
PLX
Protalix BioTherapeutics, Inc.
PLX (AMEX)
  • Financials

  • Protalix BioTherapeutics, Inc. Income Statement Annual

Annual Quarterly

* (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months) 		2024
12-31 		2023
12-31 		2022
12-31 		2021
12-31 		2020
12-31 		2019
12-31 		2018
12-31 		2017
12-31 		2016
12-31 		2015
12-31 		2014
12-31 		2013
12-31 		2012
12-31 		2011
12-31 		2010
12-31 		2009
12-31 		2008
12-31 		2007
12-31 		2006
12-31 		2005
12-31 		2004
12-31 		2003
12-31 		2002
12-31 		2001
12-31 		2000
12-31 		1999
12-31 		1998
12-31 		1997
12-31 		1996
12-31
Report Filing 2025-11-13 2025-03-17 2024-03-14 2023-02-27 2022-03-31 2021-03-30 2020-03-12 2019-03-18 2018-03-06 2017-03-16 2016-03-08 2015-03-12 2014-03-13 2013-02-28 2012-02-27 2011-02-23 2010-02-26 2009-03-06 2008-03-17 2007-03-30 2006-03-30 2005-03-31 2004-03-30 2003-03-28 2002-03-29 2001-04-16 1999-12-31 1998-12-31 1997-12-31 1996-12-31
Revenue 61.84 53.4 65.49 47.64 38.35 62.9 54.69 34.24 21.08 9.2 4.36 15.16 11.51 34.42 8.39 11.24 0.388 0 0 0.15 0.15 0.43 0 0 0 0 3.56 8.04 0 0
Cost of Revenue 26.26 24.32 22.98 19.59 16.35 10.87 10.89 9.3 15.23 8.4 0.73 9.05 5.43 8.14 1.52 4.38 3.58 0 2.25 0.035 0.035 0 0 0 0 0 2.68 6.31 0 0
Gross Profit 35.58 29.08 42.51 28.05 22 52.02 43.8 24.94 5.85 0.801 3.63 6.11 6.08 26.28 1.44 6.86 -3.19 0 0 0.115 0.115 0.31 0 0 0 0 0.871 1.73 0 0
Operating Expenses 29.21 25.16 32.05 41.06 42.46 49.31 54.52 44.25 40.36 33.96 27.3 34.67 33.2 38.45 37.97 36.83 28.78 24.17 24.57 9.82 5.9 2.73 0.147 0.166 0.386 0.382 1.69 2.9 0.164 0.044
Research & Development 18.06 12.97 17.09 29.35 29.73 38.17 44.62 33.33 28.83 30.41 20.02 27.35 29.23 28.69 31.04 29.95 21.64 17.4 12.86 5.25 3.52 0 0 0 0 0 0 0 0 0
Selling, General and Administrative 11.15 12.19 14.96 11.71 12.73 11.15 9.9 10.92 11.53 9.36 7.28 9.23 8.38 9.76 6.93 6.88 7.14 6.77 11.71 4.53 0.093 0.807 0.147 0.166 0.292 0.382 1.52 2.09 0.164 0.044
Other Operating Expenses 0 0 0 0 0 0 0 0 0 -5.8 0 -1.91 -4.41 0 0 0 0 0 0 0.048 2.29 1.92 -0 0 0.094 0 0.163 0.818 -0 0
Operating Income 6.37 3.92 10.46 -13.01 -20.46 2.71 -10.72 -19.31 -34.52 -33.16 -23.67 -28.56 -27.12 -12.17 -36.53 -29.97 -31.97 -24.17 -24.57 -9.7 -5.79 -2.42 -0.147 -0.166 -0.386 -0.382 -0.816 -1.17 -0.164 -0.044
Net Non-Operating Interest 0.117 0.237 -1.89 -1.38 -7.12 -9.23 -7.56 -7.15 -9.54 -3.6 -3.61 -4.74 0 0.554 -0.002 -0.968 0.462 1.76 2.08 0.344 0.014 0.006 0.007 0.016 0.057 0.126 0 0.027 0 0.244
Interest Income 1.09 1.3 1.29 1.15 0.401 0.438 0.407 0.536 0.188 0.589 0.123 0.196 0 0.588 0 0 0.462 1.76 2.08 0.344 0.014 0.006 0.007 0.016 0.057 0.126 0 0.079 0 0.244
Interest Expense 0.975 1.06 3.18 2.53 7.52 9.67 7.97 7.68 9.72 4.19 3.73 4.93 0 0.034 0.002 0.968 0 0 0 0 0 0 0 0 0 0 0 0.052 0 0
Equity & Other Income/(Expense) 0 0 0 0 0 0 0 0 -39.39 7.59 0 0 -0.674 0 36.53 59.93 62.95 44.83 0.006 9.02 0.029 -0.01 0.14 -0.015 -0.151 0.024 -0.255 1.15 0.343 0
Income Before Tax 6.48 4.15 8.57 -14.4 -27.58 -6.52 -18.28 -26.46 -83.44 -29.18 -27.28 -33.3 -27.79 -11.62 0.002 29 31.44 22.41 -22.48 -0.344 -5.75 -2.42 0 -0.165 -0.48 -0.232 -1.07 0 0.179 0.2
Income Tax Expense 1.09 1.22 0.254 0.53 0 0 0 0 0 0 0 -2.94 0 0 43.31 48.79 62.88 44.83 0 11.15 -0.014 0 0.141 -0.016 -0.151 -0.126 0.182 -0.027 0.061 0.068
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 0 0 0.189 -85.32 -0.411 0 0 -6.78 9.2 0 0 0 -2.07 0.014 0 0 0.001 0 0 -0.255 1.17 0 0
Net Income 5.39 2.93 8.31 -14.93 -27.58 -6.52 -18.28 -26.46 -83.44 -29.36 58.04 -29.94 -27.79 -11.62 -36.53 -29 -31.44 -22.41 -22.48 -9.43 -5.75 -2.42 -0.141 -0.15 -0.329 -0.106 -0.998 -1.15 0.118 0.132
Depreciation and Amortization 1.41 1.3 1.19 1.09 1.12 1.3 1.62 1.67 1.92 1.98 2.37 3.14 3.54 3.69 3.63 3.09 1.99 1.23 0.692 0.435 0.311 0.123 0 -0 0.094 -0.15 0.163 0.202 0 0
EBITDA 7.78 5.22 11.65 -11.93 -19.34 4.01 -9.1 -17.64 -32.6 -31.18 -21.3 -25.42 -23.58 -8.48 -32.9 -26.88 -29.98 -22.94 -23.88 -9.27 -5.48 -2.29 -0.147 -0.166 -0.292 -0.532 -0.653 -0.972 -0.164 -0.044
Earnings Per Share (EPS) 0.074 0.04 0.12 -0.31 -0.62 -0.22 -1.23 -1.8 -6.5 -0.29 0.61 -0.32 -0.3 -1.3 -4.3 -0.36 -0.41 -0.3 -3.35 -0.32 -3.1 -1.3 -0.48 -0.51 -1.02 -0.26 -19 -25 0.47 0.61
Diluted Earnings Per Share 0.07 0.037 0.1 -0.31 -0.62 -0.22 -1.23 -1.8 -6.5 -0.29 0.61 -0.32 -0.3 -1.3 -4.3 -3.6 -4.1 -0.3 -3.35 -0.32 -3.1 -1.3 -0.48 -0.51 -1.02 -3 -19 -25 0.47 0.61
Weighted Average Shares Outstanding 79.28 72.53 67.51 48.47 44.14 29.15 14.84 14.71 13.11 101.4 94.92 92.89 92.37 9.09 84.64 8.1 7.69 75.89 6.72 29.3 18.8 0.031 0.292 0.292 0.323 0.401 0.522 0.456 0.254 0.216
Diluted Weighted Average Shares Outstanding 80.81 81.06 82.42 48.47 44.14 29.15 14.84 14.71 13.11 101.4 94.92 92.89 92.37 9.09 84.64 80.96 76.94 75.89 6.72 29.3 18.8 0.031 0.292 0.292 0.323 0.401 0.522 0.456 0.254 0.216

AI Insights

What are AI Insights?

AI Insights help you understand your data more easily. With just a click, the assistant looks at the current page, generates a report with key metrics, and highlights any interesting trends, patterns, or outliers. You can also ask the assistant follow-up questions.

Create a Free Account
AI Insights Example
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program

Ready to Leave?

Select "Logout" below if you are ready to end your current session.